Nuclear imaging for cardiac amyloidosis.

about

The Prevalence and Management of Systemic Amyloidosis in Western Countries Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure.

P2860

Q26740436-F921D688-929A-4818-8FAE-20F667F55E1D Q38721841-F06DE247-FC4B-4FA3-9717-058FFD47FB62

P2860

Nuclear imaging for cardiac amyloidosis.

Item

http://www.wikidata.org/entity/Q38271439

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Nuclear imaging for cardiac amyloidosis.

@en

type

Item

label

Nuclear imaging for cardiac amyloidosis.

@en

prefLabel

Nuclear imaging for cardiac amyloidosis.

@en

P1476

Nuclear imaging for cardiac amyloidosis.

@en

P2093

Riemer H J A Slart

http://www.w3.org/2001/XMLSchema#string

Simone Longhi

http://www.w3.org/2001/XMLSchema#string

Walter Noordzij

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.

Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis.

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy.

(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis

Equilibrium radionuclide angiocardiography: Its usefulness in current practice and potential future applications.

Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

P2888

s10741-014-9463-6

P304

145-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-014-9463-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Rapezzi

Bouke P Hazenberg

Massimiliano Lorenzini

Andor W J M Glaudemans

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268878310

http://www.w3.org/2001/XMLSchema#string

P698

25424887

http://www.w3.org/2001/XMLSchema#string

Nuclear imaging for cardiac amyloidosis.

about

P2860

P2860

Nuclear imaging for cardiac amyloidosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698